Zobrazeno 1 - 10
of 166
pro vyhledávání: '"JEAN-FRANÇOIS YALE"'
Autor:
Meryem K. Talbo, Alexandra Katz, Lee Hill, Tricia M. Peters, Jean-François Yale, Anne-Sophie Brazeau
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102119- (2023)
Summary: Background: Fear of hypoglycaemia (FOH) significantly disrupts the daily management of type 1 diabetes (T1D) and increases the risk of complications. Recent technological advances can improve glucose metrics and reduce hypoglycaemia frequenc
Externí odkaz:
https://doaj.org/article/9cd949247bc9470d8d5af072a7ab7aa5
Autor:
Thozhukat Sathyapalan, Andrei-Mircea Catarig, Patrick Holmes, Jean-François Yale, Ulrik Bodholdt, Sergiu Catrina, Alice Clark, Neda Rajamand Ekberg, Umut Erhan, Søren Tang Knudsen, Joanne Liutkus, Bernd Schultes, Gottfried Rudofsky
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/c62708ce246d49819106d68b235a3c72
Autor:
Michael A Tsoukas, MD, Dorsa Majdpour, Meng, Jean-François Yale, MD, Anas El Fathi, PhD, Natasha Garfield, MD, Joanna Rutkowski, Eng, Jennifer Rene, RN, Laurent Legault, MD, Ahmad Haidar, PhD
Publikováno v:
The Lancet: Digital Health, Vol 3, Iss 11, Pp e723-e732 (2021)
Summary: Background: For people with type 1 diabetes, there is currently no automated insulin delivery system that does not require meal input. We aimed to assess the efficacy of a novel faster-acting insulin aspart (Fiasp) plus pramlintide fully clo
Externí odkaz:
https://doaj.org/article/15af37e975ca4d9787fbe206eac332ff
Autor:
Jean-François Yale, Jeremy Hodson Pettus, Miguel Brito-Sanfiel, Fernando Lavalle-Gonzalez, Ana Merino-Trigo, Peter Stella, Soazig Chevalier, Raffaella Buzzetti
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190579 (2018)
To evaluate the effect of concomitant dipeptidyl peptidase IV inhibitor (DPPIVi) use on efficacy and safety of insulin glargine 300 U/mL (Gla-300) versus glargine 100 U/mL (Gla-100) in people with type 2 diabetes on oral antihyperglycaemic drugs.A po
Externí odkaz:
https://doaj.org/article/8a5e9a7e1ac64e8eb639da9f0c475957
Autor:
Réjeanne Gougeon, John L. Sievenpiper, David Jenkins, Jean-François Yale, Rhonda Bell, Jean-Pierre Després, Thomas P. P. Ransom, Kathryn Camelon, John Dupre, Cyril Kendall, Refaat A. Hegazi, Albert Marchetti, Osama Hamdy, Jeffrey I. Mechanick
Publikováno v:
International Journal of Endocrinology, Vol 2014 (2014)
The Transcultural Diabetes Nutrition Algorithm (tDNA) is a clinical tool designed to facilitate implementation of therapeutic lifestyle recommendations for people with or at risk for type 2 diabetes. Cultural adaptation of evidence-based clinical pra
Externí odkaz:
https://doaj.org/article/f3555512344e4023b2d756ac1d114014
Autor:
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Hertzel C. Gerstein, Stewart Harris, Irene Hramiak, John Stewart, Lawrence A. Leiter
Publikováno v:
Diabetes Therapy. 14:377-386
For people with type 2 diabetes mellitus who do not achieve glycated hemoglobin A1C targets after treatment with basal insulin therapies, additional therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) may be required. One option is to
Autor:
G.B. John Mancini, Eileen O’Meara, Shelley Zieroth, Mathieu Bernier, Alice Y.Y. Cheng, David Z.I. Cherney, Kim A. Connelly, Justin Ezekowitz, Ronald M. Goldenberg, Lawrence A. Leiter, Gihad Nesrallah, Breay W. Paty, Marie-Eve Piché, Peter Senior, Abhinav Sharma, Subodh Verma, Vincent Woo, Pol Darras, Jonathan Y. Gabor, Jean Grégoire, Eva Lonn, James A. Stone, Jean-François Yale, Colin Yeung, Deborah Zimmerman
Publikováno v:
Canadian Journal of Cardiology. 38:1153-1167
Autor:
Irene Hramiak, Hertzel C. Gerstein, Lawrence A. Leiter, Jean‐François Yale, Harpreet S. Bajaj, John Stewart, Marie‐Josée Toutounji, Stewart B. Harris
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1998-2007
To compare the efficacy and safety of a simple daily titration algorithm compared with a weekly dose adjustment of iGlarLixi in people with type 2 diabetes.LixiLan ONE CAN (NCT03767543), a randomized, 26-week, open-label, multicentre phase 3 trial co
Autor:
Ahmad Haidar, Leif Erik Lovblom, Nancy Cardinez, Nikita Gouchie-Provencher, Andrej Orszag, Michael A. Tsoukas, C. Marcelo Falappa, Adnan Jafar, Milad Ghanbari, Devrim Eldelekli, Joanna Rutkowski, Jean-François Yale, Bruce A. Perkins
Publikováno v:
Nature Medicine. 28:1269-1276
There is a need to optimize closed-loop automated insulin delivery in type 1 diabetes. We assessed the glycemic efficacy and safety of empagliflozin 25 mg d
Autor:
Jean-François Yale, Beatrice Osumili, Beth D. Mitchell, Barnaby Hunt, Gurjeev Sohi, Mark Jeddi, Donna Mojdami, William J. Valentine
Publikováno v:
Journal of Medical Economics. 25:238-248
Treatments for severe hypoglycemia aim to restore blood glucose through successful administration of rescue therapy, and choosing the most effective and cost-effective option will improve outcomes for patients and may reduce costs for healthcare paye